International Society for CNS Drug Development Names Jeffrey Cummings, MD as Recipient of Leadership and Achievement Award
The International Society for CNS Drug Development (ISCDD) announced today that they have named Jeffrey Cummings, MD as the ISCDD 2018 Leadership and Achievement Award recipient. Dr. Cummings is the Director of Cleveland Clinic Lou Ruvo Center for Brain Health and the Camille and Larry Ruvo Chair for Brain Health, as well as a founding editorial board member of the magazine Practical Neurology, in which most Neurowire articles are published.
The award was given based upon Dr. Cummings’ many contributions to the field of Alzheimer’s disease (AD) and dementia research, which include over 700 articles and 43 books on AD and related topics. Cummings is also the author of the neuropsychiatric inventory (NPI), a widely used cross-validated scale that measures behavioral changes in patients with neurologic disease.
Dr. Amir Kalali, Executive Secretary of the ISCDD, stated that, "Jeff Cummings' research interests include the development of new treatments for brain disorders, with an emphasis on neurodegenerative diseases. Throughout his distinguished career, he has impacted every aspect of the field, while always remembering to put patients and their families at the center of all he does," said Dr. Kalali.
"I am honored to be recognized by my peers and fellow researchers working toward better brain health," said Dr. Cummings. "Brain health is the key to our memories, our biography and ourselves. It is the treasure that has all our friends and family in it. Nothing is more important."